Concourse Financial Group Securities’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
Concourse Financial Group Securities's ARKG Position: Q1 2025 in Review
Concourse Financial Group Securities sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2025, closing a stake of 1,104 shares — an estimated $29.9K sold.
Concourse Financial Group Securities first reported a position in ARKG in Q3 2020 and held it in 17 quarters. The position peaked at $1.3M in Q4 2021. 215 funds tracked by Wall St. Rank hold ARKG as of Q1 2025.
- Concourse Financial Group Securities reported no remaining ARK Genomic Revolution ETF position as of Q1 2025 after selling out during the quarter.
- Concourse Financial Group Securities sold 1,104 ARK Genomic Revolution ETF shares in Q1 2025, an estimated $29.9K.
- Concourse Financial Group Securities first reported a position in ARK Genomic Revolution ETF in Q3 2020 and held it in 17 quarters.
- Concourse Financial Group Securities's ARK Genomic Revolution ETF position peaked at $1.3M in Q4 2021.
- 215 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2025.
Based on Concourse Financial Group Securities's 13F filing for Q1 2025.